CEO: Behind the Scenes Can AI make illness optional?
Mar 2, 2026
Naveen Jain, founder and CEO of Viome Life Sciences, builds AI-driven molecular tests to personalize and prevent disease. He discusses why RNA and microbiome activity matter, how at-home molecular measurements can shift care from hospitals to homes, and how AI plus scale enables early disease detection and evolving, individualized recommendations.
AI Snips
Chapters
Transcript
Episode notes
Test Saliva Stool And Fingerprick Blood At Home
- Do measure multiple molecular samples at home: saliva, stool, and fingerprick blood to map gut, oral and systemic biology.
- Viome analyzes ~100 million biomarkers across those samples and builds personalized food and supplement plans monthly.
Replace Diet Dogma With Personalized Food Rules
- Avoid one-size-fits-all nutrition; follow personalized food and supplement lists tied to your biomarkers.
- Viome flags specific foods to avoid (e.g., avocado for uric acid, broccoli for sulfide) and formulates monthly custom supplements.
Personalized Interventions Yield Rapid Clinical Gains
- Personalized interventions produced measurable clinical improvements in 90 days in trials.
- Viome's RCTs showed HbA1c drops, IBS remission and reduced anxiety/depression rates versus placebo within three months.